top of page
  • Writer's picturePeter H Addy, PhD

Psychedelic-Assisted Therapy: Exploring Current Trends and Best Practices Training

In June 2023, healthcare professionals gathered virtually for a unique and cutting-edge continuing education training on psychedelic-assisted therapy. This 2-hour online session, hosted by eCare Behavioral Health Institute, offered valuable insights into the rapidly evolving field of psychedelic medicine. As a licensed professional counselor with extensive experience in psychedelic research and clinical practice, I had the privilege of leading this informative training.



The Renaissance of Psychedelic Medicine

An image of a cover slide with the title "Psychedelic-Assisted Therapy" in large text, followed by "Current Trends & Best Practices" and the author's name "Peter H Addy, PhD" in smaller text. The background is cream-colored with teal accents on the left side.
Cover slide for 'Psychedelic-Assisted Therapy: Current Trends & Best Practices' by Peter H Addy, PhD

Psychedelic-assisted therapy is not just a trend, but a significant development in the medical and mental health communities. With promising research results and increasing public interest, it's crucial for healthcare professionals to stay informed about the latest developments in this field.

Key Takeaways from the Psychedelic-Assisted Therapy Training

My training covered a wide range of topics essential for healthcare professionals interested in psychedelic-assisted therapy. We explored the science and pharmacology of psychedelics, legal considerations and access, risks and harm reduction, and the crucial aspect of integration in maximizing therapeutic benefits.

1. The Science and Pharmacology of Psychedelics

We learned about the biochemical, psychological, and spiritual effects of psychedelics, focusing on three primary substances:

  • Psilocybin

  • Ketamine

  • MDMA

Understanding the underlying mechanisms of these substances is crucial for healthcare professionals considering incorporating psychedelic-assisted therapy into their practice.

2. Legal Considerations and Access

The legal landscape surrounding psychedelics is complex and rapidly changing. We discussed:

  • Current legal avenues for psychedelic therapy

  • The difference between legalization and decriminalization

  • Ongoing clinical trials and research opportunities

3. Risks and Harm Reduction

As with any therapeutic intervention, psychedelic-assisted therapy comes with potential risks. We explored:

  • Specific risks associated with different psychedelic substances

  • Harm reduction strategies for safer practices

  • The importance of set and setting in psychedelic experiences

"Harm reduction is a compassionate approach that aims to reduce the harm caused by substance use, sexual activity, and other behaviors by valuing autonomy, respecting personal rights, and focusing on minimizing negative consequences."

4. Integration Techniques

Perhaps one of the most critical aspects of psychedelic-assisted therapy is the integration process. We discussed:

  • The importance of integration in maximizing therapeutic benefits

  • Various integration techniques, including body-based therapies, nature engagement, creative expression, and spiritual practices

  • How to support clients in incorporating insights from their psychedelic experiences into daily life

The Future of Psychedelic-Assisted Therapy

As research continues to demonstrate the potential benefits of psychedelic-assisted therapy for various mental health conditions, it becomes our responsibility as healthcare professionals to stay informed about this evolving field. The training provided by eCare Behavioral Health Institute is just one step in preparing the healthcare community for the potential widespread adoption of these therapies.


A line graph titled "Clinical Trials Over Time" shows the number of clinical trials for psilocybin and MDMA from 2004 to 2023. Both substances show a sharp increase in trials after 2018, with psilocybin trials rising more steeply than MDMA trials from 2019 onward.
Clinical trials of psilocybin and MDMA have increased dramatically in recent years, with psilocybin studies surpassing MDMA studies since 2019.

Continuing Your Education in Psychedelic-Assisted Therapy

If you're a healthcare professional interested in expanding your knowledge of psychedelic-assisted therapy, there are numerous resources available. From academic research to practical training programs, the field offers many opportunities for professional development.

Your Next Steps in Psychedelic-Affirming Education

Are you ready to deepen your understanding of psychedelic-assisted therapy and its applications in mental health treatment? Visit our store to explore our comprehensive training programs for healthcare professionals. Our courses offer in-depth knowledge, practical skills, and continuing education credits to support your professional growth in this exciting field.



As the field of psychedelic-assisted therapy continues to evolve, staying informed and well-trained is crucial. Join us in exploring the potential of these groundbreaking therapies to transform mental health care and improve patient outcomes.

Comments


Commenting has been turned off.
bottom of page